Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction

Jiunn Tay Lee, Chung Hsing Chou, Nai Yu Cho, Yueh Feng Sung, Fu Chi Yang, Cheng Yu Chen, Yu Hua Lai, Chun I. Chiang, Chi Ming Chu, Jiann Chyun Lin, Yaw Don Hsu, Jau Shyong Hong, Giia Sheun Peng, De Maw Chuang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Animal stroke models suggest that valproate has multiple neuroprotective mechanisms against ischemic brain damage. This study investigated whether valproate improves functional recovery in patients with acute middle cerebral artery (MCA) infarction. This was an open-label controlled trial. Three to 24 hours after acute MCA infarction, patients were assigned to either the valproate group (n = 17) or the non-valproate group (n = 17). The valproate group received intravenous valproate (400 mg) at enrollment, and then every 12 hours for three days, followed by oral valproate (500 mg) every 12 hours for three months. Neurological function, laboratory data, and brain magnetic resonance imaging were examined at stroke onset, and at two-week and three-month follow-up. No signifcant differences were observed between the groups with regard to demographics or baseline characteristics. All patients were elderly, had a high pretreatment score on the NIH stroke scale (NIHSS), and slow stroke lesion growth with a fnal large infarct volume at two-week follow-up. At the three-month follow-up, functional outcome between pre- and post-treatment had improved signifcantly in the valproate group (NIHSS, p = 0.004; modifed Rankin scale (mRS), p = 0.007; Barthel index (BI), p = 0.001). No such improvement was noted in the NIHSS or mRS for the non-valproate group, though mild improvement was seen on the BI (p = 0.022). This open-label trial is the frst to demonstrate that valproate treatment markedly improves functional outcome in patients with acute MCA infarction.

Original languageEnglish
Pages (from-to)820-830
Number of pages11
JournalAmerican Journal of Translational Research
Volume6
Issue number6
Publication statusPublished - 2014

Fingerprint

Middle Cerebral Artery Infarction
Valproic Acid
Recovery
Stroke
Therapeutics
Labels
Brain
Magnetic resonance
Animals
Animal Models
Magnetic Resonance Imaging
Demography
Imaging techniques
Growth

Keywords

  • Ischemic stroke
  • Neuroprotection
  • Stroke outcome
  • Valproate

ASJC Scopus subject areas

  • Medicine(all)
  • Cancer Research
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction. / Lee, Jiunn Tay; Chou, Chung Hsing; Cho, Nai Yu; Sung, Yueh Feng; Yang, Fu Chi; Chen, Cheng Yu; Lai, Yu Hua; Chiang, Chun I.; Chu, Chi Ming; Lin, Jiann Chyun; Hsu, Yaw Don; Hong, Jau Shyong; Peng, Giia Sheun; Chuang, De Maw.

In: American Journal of Translational Research, Vol. 6, No. 6, 2014, p. 820-830.

Research output: Contribution to journalArticle

Lee, JT, Chou, CH, Cho, NY, Sung, YF, Yang, FC, Chen, CY, Lai, YH, Chiang, CI, Chu, CM, Lin, JC, Hsu, YD, Hong, JS, Peng, GS & Chuang, DM 2014, 'Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction', American Journal of Translational Research, vol. 6, no. 6, pp. 820-830.
Lee, Jiunn Tay ; Chou, Chung Hsing ; Cho, Nai Yu ; Sung, Yueh Feng ; Yang, Fu Chi ; Chen, Cheng Yu ; Lai, Yu Hua ; Chiang, Chun I. ; Chu, Chi Ming ; Lin, Jiann Chyun ; Hsu, Yaw Don ; Hong, Jau Shyong ; Peng, Giia Sheun ; Chuang, De Maw. / Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction. In: American Journal of Translational Research. 2014 ; Vol. 6, No. 6. pp. 820-830.
@article{05098d58348945dbbd2490ee85ade69c,
title = "Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction",
abstract = "Animal stroke models suggest that valproate has multiple neuroprotective mechanisms against ischemic brain damage. This study investigated whether valproate improves functional recovery in patients with acute middle cerebral artery (MCA) infarction. This was an open-label controlled trial. Three to 24 hours after acute MCA infarction, patients were assigned to either the valproate group (n = 17) or the non-valproate group (n = 17). The valproate group received intravenous valproate (400 mg) at enrollment, and then every 12 hours for three days, followed by oral valproate (500 mg) every 12 hours for three months. Neurological function, laboratory data, and brain magnetic resonance imaging were examined at stroke onset, and at two-week and three-month follow-up. No signifcant differences were observed between the groups with regard to demographics or baseline characteristics. All patients were elderly, had a high pretreatment score on the NIH stroke scale (NIHSS), and slow stroke lesion growth with a fnal large infarct volume at two-week follow-up. At the three-month follow-up, functional outcome between pre- and post-treatment had improved signifcantly in the valproate group (NIHSS, p = 0.004; modifed Rankin scale (mRS), p = 0.007; Barthel index (BI), p = 0.001). No such improvement was noted in the NIHSS or mRS for the non-valproate group, though mild improvement was seen on the BI (p = 0.022). This open-label trial is the frst to demonstrate that valproate treatment markedly improves functional outcome in patients with acute MCA infarction.",
keywords = "Ischemic stroke, Neuroprotection, Stroke outcome, Valproate",
author = "Lee, {Jiunn Tay} and Chou, {Chung Hsing} and Cho, {Nai Yu} and Sung, {Yueh Feng} and Yang, {Fu Chi} and Chen, {Cheng Yu} and Lai, {Yu Hua} and Chiang, {Chun I.} and Chu, {Chi Ming} and Lin, {Jiann Chyun} and Hsu, {Yaw Don} and Hong, {Jau Shyong} and Peng, {Giia Sheun} and Chuang, {De Maw}",
year = "2014",
language = "English",
volume = "6",
pages = "820--830",
journal = "American Journal of Translational Research",
issn = "1943-8141",
publisher = "e-Century Publishing Corporation",
number = "6",

}

TY - JOUR

T1 - Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction

AU - Lee, Jiunn Tay

AU - Chou, Chung Hsing

AU - Cho, Nai Yu

AU - Sung, Yueh Feng

AU - Yang, Fu Chi

AU - Chen, Cheng Yu

AU - Lai, Yu Hua

AU - Chiang, Chun I.

AU - Chu, Chi Ming

AU - Lin, Jiann Chyun

AU - Hsu, Yaw Don

AU - Hong, Jau Shyong

AU - Peng, Giia Sheun

AU - Chuang, De Maw

PY - 2014

Y1 - 2014

N2 - Animal stroke models suggest that valproate has multiple neuroprotective mechanisms against ischemic brain damage. This study investigated whether valproate improves functional recovery in patients with acute middle cerebral artery (MCA) infarction. This was an open-label controlled trial. Three to 24 hours after acute MCA infarction, patients were assigned to either the valproate group (n = 17) or the non-valproate group (n = 17). The valproate group received intravenous valproate (400 mg) at enrollment, and then every 12 hours for three days, followed by oral valproate (500 mg) every 12 hours for three months. Neurological function, laboratory data, and brain magnetic resonance imaging were examined at stroke onset, and at two-week and three-month follow-up. No signifcant differences were observed between the groups with regard to demographics or baseline characteristics. All patients were elderly, had a high pretreatment score on the NIH stroke scale (NIHSS), and slow stroke lesion growth with a fnal large infarct volume at two-week follow-up. At the three-month follow-up, functional outcome between pre- and post-treatment had improved signifcantly in the valproate group (NIHSS, p = 0.004; modifed Rankin scale (mRS), p = 0.007; Barthel index (BI), p = 0.001). No such improvement was noted in the NIHSS or mRS for the non-valproate group, though mild improvement was seen on the BI (p = 0.022). This open-label trial is the frst to demonstrate that valproate treatment markedly improves functional outcome in patients with acute MCA infarction.

AB - Animal stroke models suggest that valproate has multiple neuroprotective mechanisms against ischemic brain damage. This study investigated whether valproate improves functional recovery in patients with acute middle cerebral artery (MCA) infarction. This was an open-label controlled trial. Three to 24 hours after acute MCA infarction, patients were assigned to either the valproate group (n = 17) or the non-valproate group (n = 17). The valproate group received intravenous valproate (400 mg) at enrollment, and then every 12 hours for three days, followed by oral valproate (500 mg) every 12 hours for three months. Neurological function, laboratory data, and brain magnetic resonance imaging were examined at stroke onset, and at two-week and three-month follow-up. No signifcant differences were observed between the groups with regard to demographics or baseline characteristics. All patients were elderly, had a high pretreatment score on the NIH stroke scale (NIHSS), and slow stroke lesion growth with a fnal large infarct volume at two-week follow-up. At the three-month follow-up, functional outcome between pre- and post-treatment had improved signifcantly in the valproate group (NIHSS, p = 0.004; modifed Rankin scale (mRS), p = 0.007; Barthel index (BI), p = 0.001). No such improvement was noted in the NIHSS or mRS for the non-valproate group, though mild improvement was seen on the BI (p = 0.022). This open-label trial is the frst to demonstrate that valproate treatment markedly improves functional outcome in patients with acute MCA infarction.

KW - Ischemic stroke

KW - Neuroprotection

KW - Stroke outcome

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=84912097781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912097781&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84912097781

VL - 6

SP - 820

EP - 830

JO - American Journal of Translational Research

JF - American Journal of Translational Research

SN - 1943-8141

IS - 6

ER -